相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEFaEuro
B. Chauffert et al.
ANNALS OF ONCOLOGY (2014)
Bevacizumab for the treatment of high-grade glioma: an update after Phase Ill trials
Mustafa Khasraw et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort
Yazmin Odia et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas
Johannes Thaler et al.
NEURO-ONCOLOGY (2014)
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma
Jennifer L. Clarke et al.
NEURO-ONCOLOGY (2014)
Safety of bevacizumab in patients with malignant gliomas: a systematic review
G. Simonetti et al.
NEUROLOGICAL SCIENCES (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Thrombosis in Brain Tumors
Jasmin T. Jo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ADDITION OF BEVACIZUMAB TO STANDARD RADIATION THERAPY AND DAILY TEMOZOLOMIDE IS ASSOCIATED WITH MINIMAL TOXICITY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
James J. Vredenburgh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients
Andrew D. Norden et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Primary brain tumours in adults
Damien Ricard et al.
LANCET (2012)
Treatment-Related Mortality With Bevacizumab in Cancer Patients A Meta-analysis
Vishal Ranpura et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Venous thromboembolism in malignant gliomas
E. O. Jenkins et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Comparison of two methods to detect publication bias in meta-analysis
JL Peters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
